3D heart scans may improve monitoring after valve surgery
NCT ID NCT05804240
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study used a special 3D ultrasound technique (called 3D transesophageal echocardiography) to measure how well the right side of the heart works in 67 adults who had one of three types of aortic valve replacement. The goal was to see if this method can reliably track changes in right heart function after surgery. The study is complete and may help doctors better monitor recovery in the future.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better monitor right heart function after aortic valve replacement, potentially improving patient care.
- What could go wrong
- This is a small, completed observational study. It does not test a treatment, so it cannot directly change patient outcomes. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
67 people
The number who actually took part.
- Started
-
Apr 2023
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients who had SAVR, mini AVR, and TAVR at Thomas Jefferson University Hospital
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients over 18 years old * Patients who had SAVR, mini AVR, or TAVR Exclusion criteria: * Patients' refusal * Suboptimal echocardiography data for RVEF, RV size, RIMP, RVFAC, TAPSE, S', STE
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Right ventricular dysfunction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pacemaker trick may boost failing right heart in lung disease
- New study aims to protect hearts of ARDS patients on ventilators
- Could a $4 blood pressure pill ease a rare lung disease?
- Study aims to uncover hidden heart strain during ICU fluid therapy
- Iron pills may boost exercise in thin air, tiny study hints
- Pacemaker showdown: which new technology is safer for your heart?